UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1632) 1632
life sciences & biomedicine (1430) 1430
animals (1259) 1259
humans (918) 918
protozoan proteins - antagonists & inhibitors (859) 859
protozoan proteins - metabolism (796) 796
biochemistry & molecular biology (580) 580
protozoan proteins - genetics (519) 519
parasitic diseases (471) 471
malaria (409) 409
parasitology (401) 401
protozoan proteins - chemistry (378) 378
microbiology (374) 374
mice (356) 356
biological and medical sciences (343) 343
amino acid sequence (337) 337
molecular sequence data (332) 332
parasites (329) 329
enzyme inhibitors - pharmacology (304) 304
plasmodium falciparum - drug effects (303) 303
antimalarials - pharmacology (291) 291
plasmodium falciparum - enzymology (291) 291
proteins (286) 286
infectious diseases (282) 282
plasmodium falciparum (280) 280
pharmacology & pharmacy (269) 269
research article (254) 254
immunology (251) 251
models, molecular (226) 226
cell biology (220) 220
research (209) 209
enzymes (206) 206
structure-activity relationship (205) 205
multidisciplinary sciences (195) 195
science & technology - other topics (195) 195
medical sciences (192) 192
protein binding (190) 190
binding sites (187) 187
plasmodium falciparum - genetics (185) 185
female (183) 183
fundamental and applied biological sciences. psychology (182) 182
analysis (181) 181
kinetics (178) 178
protozoa (178) 178
gene expression (174) 174
chemistry, medicinal (164) 164
antimalarials - chemistry (160) 160
chemistry (153) 153
physical sciences (153) 153
biochemistry (152) 152
enzyme inhibitors - chemistry (152) 152
drug design (148) 148
physiological aspects (148) 148
medicine (146) 146
biology (144) 144
protozoan proteins (144) 144
drug resistance (137) 137
antiprotozoal agents - pharmacology (136) 136
recombinant proteins - metabolism (132) 132
pharmacology. drug treatments (129) 129
erythrocytes - parasitology (126) 126
science (125) 125
plasmodium falciparum - metabolism (123) 123
molecular structure (122) 122
health aspects (120) 120
infections (120) 120
vector-borne diseases (120) 120
sequence alignment (118) 118
trypanosoma cruzi - enzymology (116) 116
mice, inbred balb c (113) 113
tropical medicine (113) 113
trypanocidal agents - pharmacology (113) 113
cells, cultured (112) 112
sequence homology, amino acid (111) 111
signal transduction (111) 111
inhibitors (109) 109
antibiotics. antiinfectious agents. antiparasitic agents (108) 108
life sciences (108) 108
drug discovery (107) 107
cloning, molecular (106) 106
substrate specificity (106) 106
trypanosoma brucei brucei - enzymology (106) 106
recombinant proteins - genetics (104) 104
molecular docking simulation (103) 103
mutation (103) 103
biophysics (99) 99
biology and life sciences (98) 98
male (98) 98
trypanosoma cruzi - drug effects (97) 97
aspartic acid endopeptidases - antagonists & inhibitors (96) 96
base sequence (96) 96
cell line (94) 94
trypanosoma cruzi (94) 94
crystallography, x-ray (93) 93
genetic aspects (92) 92
inhibitory concentration 50 (92) 92
malaria, falciparum - parasitology (92) 92
antiparasitic agents (91) 91
genes, protozoan (91) 91
ligands (90) 90
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1932) 1932
Japanese (7) 7
German (6) 6
Russian (5) 5
Spanish (5) 5
Portuguese (4) 4
French (3) 3
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The FEBS journal, ISSN 1742-464X, 10/2014, Volume 281, Issue 19, pp. 4519 - 4534
Plasmodium falciparum | protein–protein interaction | NMR spectroscopy | protein phosphatase type 1 | PP1 inhibitor 2 | Plasmodium falciparum | Protein-protein interaction | Protein phosphatase type 1 | PP1 inhibitor 2 | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Plasmodium falciparum - enzymology | Protein Phosphatase 1 - physiology | Protein Phosphatase 1 - chemistry | Protozoan Proteins - antagonists & inhibitors | Humans | Molecular Sequence Data | Plasmodium falciparum - drug effects | Enzyme Inhibitors - chemistry | Protozoan Proteins - chemistry | Protein Interaction Domains and Motifs | Drug Evaluation, Preclinical | Amino Acid Sequence | Antimalarials - metabolism | Enzyme Inhibitors - metabolism | Xenopus laevis | Cells, Cultured | Enzyme Inhibitors - pharmacology | Protozoan Proteins - physiology | Amino Acid Motifs | Antimalarials - pharmacology | Protein Phosphatase 1 - antagonists & inhibitors | Animals | Antimalarials - chemistry | Protein Binding | Erythrocytes - parasitology | Proteins | Phosphatases | Malaria | Nuclear magnetic resonance spectroscopy | Chemical properties | Amphibians | Protein-protein interactions | Protein binding | Enzymes | Peptides | Molecular biology | Erythrocytes | Index Medicus | Protein Phosphatase 1/chemistry | Enzyme Inhibitors/metabolism | Enzyme Inhibitors/pharmacology | Plasmodium falciparum/drug effects | Antimalarials/pharmacology | Life Sciences | Protein Phosphatase 1/physiology | Biomolecules | Erythrocytes/parasitology | Enzyme Inhibitors/chemistry | Protozoan Proteins/physiology | Biochemistry, Molecular Biology | Protozoan Proteins/chemistry | Protein Phosphatase 1/antagonists & inhibitors | Protozoan Proteins/antagonists & inhibitors | Antimalarials/metabolism | Antimalarials/chemistry | Plasmodium falciparum/enzymology
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 12/2017, Volume 22, Issue 12, p. 2139
PfHsp70-1 | Plasmodium falciparum | (−)-epigallocatechin-3-gallate | Functional associates | Malaria | PfHsp70-z | Inhibitor | Molecular chaperone | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | HSP70 Heat-Shock Proteins - antagonists & inhibitors | Protozoan Proteins - antagonists & inhibitors | Humans | Cytosol - drug effects | Plasmodium falciparum - drug effects | Protozoan Proteins - genetics | Protein Isoforms - metabolism | Protozoan Proteins - metabolism | Protein Isoforms - chemistry | Plasmodium falciparum - genetics | Cloning, Molecular | Escherichia coli - metabolism | Inhibitory Concentration 50 | Plasmodium falciparum - metabolism | Protozoan Proteins - chemistry | HSP70 Heat-Shock Proteins - chemistry | Protein Interaction Domains and Motifs | Catechin - pharmacology | Binding Sites | Protein Structure, Tertiary | Recombinant Proteins - metabolism | Gene Expression | Protein Structure, Secondary | Recombinant Proteins - chemistry | HSP70 Heat-Shock Proteins - genetics | Recombinant Proteins - genetics | Antimalarials - pharmacology | Erythrocytes - drug effects | HSP70 Heat-Shock Proteins - metabolism | Escherichia coli - genetics | Antimalarials - chemistry | Protein Binding | Cytosol - metabolism | Catechin - analogs & derivatives | Plasmodium falciparum - growth & development | Erythrocytes - parasitology | Catechin - chemistry | Protein Isoforms - antagonists & inhibitors | Protein Isoforms - genetics | Vector-borne diseases | Hsp90 protein | Erythrocytes | Epigallocatechin-3-gallate | Heat shock proteins | Hsp70 protein | Parasites | Chaperones | Cytosol | Proteins | Tea | Protein folding | Isoforms | Surface plasmon resonance | Inhibition | Green tea | Antiprotozoal agents | Adenosine triphosphatase | Heat shock | Index Medicus | molecular chaperone | inhibitor | functional associates | malaria
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 08/2015, Volume 290, Issue 32, pp. 19987 - 19998
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | RNA, Protozoan - genetics | RNA, Small Interfering - genetics | RNA-Binding Proteins - genetics | Proteome - genetics | Protozoan Proteins - antagonists & inhibitors | Humans | Molecular Sequence Data | Protozoan Proteins - genetics | RNA, Messenger - metabolism | Gene Knockdown Techniques | Peptides - metabolism | Protozoan Proteins - metabolism | RNA, Messenger - antagonists & inhibitors | Escherichia coli - metabolism | Lysine - metabolism | Microfilament Proteins - metabolism | Flagella - genetics | Peptide Initiation Factors - antagonists & inhibitors | Microfilament Proteins - genetics | RNA-Binding Proteins - antagonists & inhibitors | Recombinant Proteins - metabolism | Amino Acid Sequence | Lysine - analogs & derivatives | Flagella - ultrastructure | Trypanosoma brucei brucei - metabolism | RNA, Messenger - genetics | RNA, Protozoan - antagonists & inhibitors | Recombinant Proteins - genetics | Trypanosoma brucei brucei - genetics | Peptide Initiation Factors - metabolism | Sequence Homology, Amino Acid | Peptide Initiation Factors - genetics | RNA, Protozoan - metabolism | Trypanosoma brucei brucei - ultrastructure | Sequence Alignment | Animals | Flagella - metabolism | Escherichia coli - genetics | Protein Processing, Post-Translational | Proteome - metabolism | RNA-Binding Proteins - metabolism | RNA, Small Interfering - metabolism | Index Medicus | parasite metabolism | polyamine | spermidine | hypusine | Microbiology | eukaryotic initiation factor 5A (eIF5A) | Trypanosoma brucei
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 9/2010, Volume 329, Issue 5996, pp. 1175 - 1180
Malaria | Artemisinins | RESEARCH ARTICLES | Genomics | Adenosine triphosphatases | Antimalarials | Parasites | Inhibitory concentration 50 | Drug resistance | Dosage | Genetic mutation | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Infectious diseases | Parasitic diseases | Pharmacology. Drug treatments | Protozoal diseases | Biological and medical sciences | Antiparasitic agents | Human protozoal diseases | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Parasitic Sensitivity Tests | Humans | Male | Plasmodium falciparum - drug effects | Indoles - administration & dosage | Plasmodium falciparum - genetics | Protein Synthesis Inhibitors - pharmacology | Mutant Proteins - antagonists & inhibitors | Antimalarials - pharmacokinetics | Adenosine Triphosphatases - metabolism | Models, Molecular | Rats | Spiro Compounds - pharmacokinetics | Adenosine Triphosphatases - antagonists & inhibitors | Antimalarials - administration & dosage | Malaria - parasitology | Adenosine Triphosphatases - genetics | Mice | Mutation | Erythrocytes - parasitology | Plasmodium berghei - drug effects | Plasmodium vivax - growth & development | Protein Synthesis Inhibitors - chemistry | Rats, Wistar | Spiro Compounds - administration & dosage | Genes, Protozoan | Protozoan Proteins - genetics | Protein Synthesis Inhibitors - administration & dosage | Protozoan Proteins - metabolism | Female | Indoles - pharmacology | Protozoan Proteins - chemistry | Drug Resistance | Spiro Compounds - chemistry | Cell Line | Plasmodium vivax - drug effects | Mutant Proteins - metabolism | Drug Discovery | Protozoan Proteins - biosynthesis | Antimalarials - pharmacology | Protein Synthesis Inhibitors - pharmacokinetics | Animals | Mutant Proteins - chemistry | Antimalarials - chemistry | Adenosine Triphosphatases - chemistry | Indoles - pharmacokinetics | Malaria - drug therapy | Plasmodium falciparum - growth & development | Indoles - chemistry | Spiro Compounds - pharmacology | Research | Pharmacology | Inhibitor drugs | Drug therapy | Protein synthesis | Drugs | Mutations | Nanomaterials | Encoding | Cations | Nanostructure | Ablation | Index Medicus
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 02/2016, Volume 44, Issue 2, pp. 246 - 258
Journal Article